[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Insmed, Inc.](/topic/$insm)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$insm/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +3%  
**6 Months**: XX% -X%  
**1 Year**: XX% +23%  
**1-Year High**: XXX% on 2024-07-27  
**1-Year Low**: XX% on 2025-03-03  

**Most Supportive Themes**
- **Analyst activity:** (45%) Analysts are increasing their positions in INSM, reflecting confidence.
- **Clinical trial success:** (35%) Positive trial data for brensocatib in treating fibrosis bronchiectasis is driving interest.
- **Positive social media engagement:** (15%) Increased social media engagements from influential accounts are fueling positive attention.
  
**Most Critical Themes**
- **Competitive Landscape:** (5%)  Discussions of competitors may present challenges to Insmed, Inc.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |